- BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
BNP-7787 (BioNumerik/Baxter Oncology/Grelan).
IDrugs : the investigational drugs journal (2004-01-20)
R Todd Reilly
PMID14730469
RESUMO
BioNumerik Pharmacology Inc, Baxter Oncology GmbH (formerly ASTA Medica AG) and Grelan Pharmaceutical Co Ltd are developing BNP-7787 for the potential reduction of toxicity associated with cisplatin and carboplatin treatment in cancer patients.
MATERIAIS
Número do produto
Marca
Descrição do produto
Mesna impurity D, European Pharmacopoeia (EP) Reference Standard